Olaparib, Durvalumab and UV1 in Relapsed Ovarian Cancer

NCT04742075 · clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
188
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

Collaborators